Moderna Reveals COVID-19 Vaccine Nearly 95% Effective In Latest “Breakthrough” Results

US biotech firm Mod­er­na on Mon­day announced its exper­i­men­tal vac­cine against Covid-19 was almost 95 per­cent effec­tive, mark­ing a sec­ond major break­through in the quest to end the pandemic.

Mod­er­na released ear­ly results from a clin­i­cal tri­al with more than 30,000 par­tic­i­pants, after Amer­i­can phar­ma­ceu­ti­cal com­pa­ny Pfiz­er and its Ger­man part­ner BioN­Tech last week said their vac­cine was 90 per­cent effective.

Both fron­trun­ners are based on new tech­nol­o­gy that uses syn­thet­ic ver­sions of mol­e­cules called “mes­sen­ger RNA” to hack into human cells, and effec­tive­ly turn them into vac­cine-mak­ing factories.

“This pos­i­tive inter­im analy­sis from our Phase 3 study has giv­en us the first clin­i­cal val­i­da­tion that our vac­cine can pre­vent COVID-19 dis­ease, includ­ing severe dis­ease,” said Mod­er­na CEO Stephane Bancel.

ANNOUNCEMENT

Big Tech is at war with you! They don't want you to see the truth. Bookmark us and visit daily. 

JOIN OUR POPULAR NEWSLETTER

Send this to a friend